The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer.

Kim, S T; Do, I-G; Lee, J; Sohn, I; Kim, K-M; Kang, W K.
Clin Transl Oncol; 17(6): 462-8, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25445175